APA (7th ed.) Citation

Cavalcanti, F., Gonzalez-Rey, E., Delgado, M., Falo, C. P., Mestre, L., Guaza, C., . . . Maes, T. (2022). Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis. Pharmaceutics, 14(7), N.PAG. https://doi.org/10.3390/pharmaceutics14071420

Chicago Style (17th ed.) Citation

Cavalcanti, Fernando, et al. "Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis." Pharmaceutics 14, no. 7 (2022): N.PAG. https://doi.org/10.3390/pharmaceutics14071420.

MLA (9th ed.) Citation

Cavalcanti, Fernando, et al. "Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis." Pharmaceutics, vol. 14, no. 7, 2022, p. N.PAG, https://doi.org/10.3390/pharmaceutics14071420.